Gain Therapeutics names Joanne Taylor chief scientific officer, promotes Terenzio Ignoni to COO

Gain Therapeutics, Inc.

Gain Therapeutics, Inc.

GANX

0.00
  • Gain Therapeutics promoted Joanne Taylor to chief scientific officer, shifting her from senior vice president, research.
  • Taylor joined in 2020; previously led neuroscience at Prescient Healthcare Group; held senior neuroscience research leadership roles at Eisai.
  • Terenzio Ignoni was promoted to chief operating officer from senior vice president, technical operations and development.
  • Ignoni joined in 2021; previously served as vice president, quality at Jazz Pharmaceuticals; held leadership roles at Gentium and Zambon Group.
  • Clinical development executive Jonas Hannestad will depart in July 2026, following work on rexaceract’s early clinical program and IND filing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gain Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607160700PRIMZONEFULLFEED9763242) on July 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.